Works by Maeda, Yasuhiro


Results: 120
    1
    2

    Insights from the ganglionic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome.

    Published in:
    Modern Rheumatology, 2016, v. 26, n. 5, p. 708, doi. 10.3109/14397595.2016.1147404
    By:
    • Akihiro Mukaino;
    • Shunya Nakane;
    • Osamu Higuchi;
    • Hideki Nakamura;
    • Tomo Miyagi;
    • Kanako Shiroma;
    • Takashi Tokashiki;
    • Yasuhiro Fuseya;
    • Kazuhide Ochi;
    • Masataka Umeda;
    • Tetsuya Nakazato;
    • Shinji Akioka;
    • Hiroyuki Maruoka;
    • Masatoshi Hayashi;
    • Shu-ichi Igarashi;
    • Katsunori Yokoi;
    • Yasuhiro Maeda;
    • Waka Sakai;
    • Hidenori Matsuo;
    • Atsushi Kawakami
    Publication type:
    Article
    3

    Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome.

    Published in:
    European Journal of Haematology, 2007, v. 78, n. 3, p. 213, doi. 10.1111/j.1600-0609.2006.00803.x
    By:
    • Yanada, Masamitsu;
    • Matsushita, Tadashi;
    • Asou, Norio;
    • Kishimoto, Yuji;
    • Tsuzuki, Motohiro;
    • Maeda, Yasuhiro;
    • Horikawa, Kentaro;
    • Okada, Masaya;
    • Ohtake, Shigeki;
    • Yagasaki, Fumiharu;
    • Matsumoto, Tadashi;
    • Kimura, Yukihiko;
    • Shinagawa, Katsuji;
    • Iwanaga, Masako;
    • Miyazaki, Yasushi;
    • Ohno, Ryuzo;
    • Naoe, Tomoki
    Publication type:
    Article
    4

    Low absolute lymphocyte count is a poor prognostic factor for untreated advanced follicular lymphoma treated with rituximab plus bendamustine: results of the prospective phase 2 CONVERT trial.

    Published in:
    International Journal of Hematology, 2021, v. 114, n. 2, p. 205, doi. 10.1007/s12185-021-03148-0
    By:
    • Rai, Shinya;
    • Inoue, Hiroaki;
    • Hanamoto, Hitoshi;
    • Matsuda, Mitsuhiro;
    • Maeda, Yasuhiro;
    • Wada, Yusuke;
    • Haeno, Takahiro;
    • Watatani, Yosaku;
    • Kumode, Takahiro;
    • Hirase, Chikara;
    • Espinoza, J. Luis;
    • Morita, Yasuyoshi;
    • Tanaka, Hirokazu;
    • Tatsumi, Yoichi;
    • Matsumura, Itaru
    Publication type:
    Article
    5

    Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL: a 36-month analysis of a phase I and II study.

    Published in:
    International Journal of Hematology, 2012, v. 95, n. 4, p. 409, doi. 10.1007/s12185-012-1026-9
    By:
    • Usuki, Kensuke;
    • Tojo, Arinobu;
    • Maeda, Yasuhiro;
    • Kobayashi, Yukio;
    • Matsuda, Akira;
    • Ohyashiki, Kazuma;
    • Nakaseko, Chiaki;
    • Kawaguchi, Tatsuya;
    • Tanaka, Hideo;
    • Miyamura, Koichi;
    • Miyazaki, Yasushi;
    • Okamoto, Shinichiro;
    • Oritani, Kenji;
    • Okada, Masaya;
    • Usui, Noriko;
    • Nagai, Tadashi;
    • Amagasaki, Taro;
    • Wanajo, Aira;
    • Naoe, Tomoki
    Publication type:
    Article
    6
    7

    Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study.

    Published in:
    2010
    By:
    • Jinnai, Itsuro;
    • Sakura, Tohru;
    • Tsuzuki, Motohiro;
    • Maeda, Yasuhiro;
    • Usui, Noriko;
    • Kato, Masayuki;
    • Okumura, Hirokazu;
    • Kyo, Taiichi;
    • Ueda, Yasunori;
    • Kishimoto, Yuji;
    • Yagasaki, Fumiharu;
    • Tsuboi, Kosuke;
    • Horiike, Shigeo;
    • Takeuchi, Jin;
    • Iwanaga, Masako;
    • Miyazaki, Yasushi;
    • Miyawaki, Shuichi;
    • Ohnishi, Kazunori;
    • Naoe, Tomoki;
    • Ohno, Ryuzo
    Publication type:
    journal article
    8

    Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia: the JALSG AML95 study.

    Published in:
    2010
    By:
    • Ohtake, Shigeki;
    • Miyawaki, Shuichi;
    • Kiyoi, Hitoshi;
    • Miyazaki, Yasushi;
    • Okumura, Hirokazu;
    • Matsuda, Shin;
    • Nagai, Tadashi;
    • Kishimoto, Yuji;
    • Okada, Masaya;
    • Takahashi, Masatomo;
    • Handa, Hiroshi;
    • Takeuchi, Jin;
    • Kageyama, Shinichi;
    • Asou, Norio;
    • Yagasaki, Fumiharu;
    • Maeda, Yasuhiro;
    • Ohnishi, Kazunori;
    • Naoe, Tomoki;
    • Ohno, Ryuzo
    Publication type:
    journal article
    9
    10
    11
    12
    13
    14
    15

    Decreased expression of T‐cell‐associated immune markers predicts poor prognosis in patients with follicular lymphoma.

    Published in:
    Cancer Science, 2022, v. 113, n. 2, p. 660, doi. 10.1111/cas.15224
    By:
    • Rai, Shinya;
    • Inoue, Hiroaki;
    • Sakai, Kazuko;
    • Hanamoto, Hitoshi;
    • Matsuda, Mitsuhiro;
    • Maeda, Yasuhiro;
    • Haeno, Takahiro;
    • Watatani, Yosaku;
    • Kumode, Takahiro;
    • Serizawa, Kentaro;
    • Taniguchi, Yasuhiro;
    • Hirase, Chikara;
    • Espinoza, J. Luis;
    • Morita, Yasuyoshi;
    • Tanaka, Hirokazu;
    • Ashida, Takashi;
    • Tatsumi, Yoichi;
    • Nishio, Kazuto;
    • Matsumura, Itaru
    Publication type:
    Article
    16
    17
    18
    19

    Clinical significance of tryptophan catabolism in Hodgkin lymphoma.

    Published in:
    Cancer Science, 2018, v. 109, n. 1, p. 74, doi. 10.1111/cas.13432
    By:
    • Masaki, Ayako;
    • Ishida, Takashi;
    • Maeda, Yasuhiro;
    • Ito, Asahi;
    • Suzuki, Susumu;
    • Narita, Tomoko;
    • Kinoshita, Shiori;
    • Takino, Hisashi;
    • Yoshida, Takashi;
    • Ri, Masaki;
    • Kusumoto, Shigeru;
    • Komatsu, Hirokazu;
    • Inagaki, Hiroshi;
    • Ueda, Ryuzo;
    • Choi, Ilseung;
    • Suehiro, Youko;
    • Iida, Shinsuke
    Publication type:
    Article
    20

    Long-term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 study.

    Published in:
    Cancer Science, 2012, v. 103, n. 6, p. 1071, doi. 10.1111/j.1349-7006.2012.02253.x
    By:
    • Ohnishi, Kazunori;
    • Nakaseko, Chiaki;
    • Takeuchi, Jin;
    • Fujisawa, Shin;
    • Nagai, Tadashi;
    • Yamazaki, Hirohito;
    • Tauchi, Tetsuzo;
    • Imai, Kiyotoshi;
    • Mori, Naoki;
    • Yagasaki, Fumiharu;
    • Maeda, Yasuhiro;
    • Usui, Noriko;
    • Miyazaki, Yasushi;
    • Miyamura, Koichi;
    • Kiyoi, Hitoshi;
    • Ohtake, Shigeki;
    • Naoe, Tomoki
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27

    mTOR inhibition and adult T-cell leukemia.

    Published in:
    Leukemia & Lymphoma, 2009, v. 50, n. 4, p. 645, doi. 10.1080/10428190802709446
    By:
    • Hirase, Chikara;
    • Maeda, Yasuhiro;
    • Yamaguchi, Terufumi;
    • Miyatake, Jun-Ichi;
    • Kanamaru, Akihisa
    Publication type:
    Article
    28

    Possible molecular target therapy with rapamycin in MDS.

    Published in:
    Leukemia & Lymphoma, 2006, v. 47, n. 5, p. 907, doi. 10.1080/10428190500467859
    By:
    • Maeda, Yasuhiro;
    • Yamaguchi, Terufumi;
    • Hijikata, Yasuki;
    • Matsuoka, Toshiaki;
    • Tanaka, Miyako;
    • Morita, Yasuyoshi;
    • Hirase, Chikara;
    • Takai, Shunsuke;
    • Tatsumi, Yoichi;
    • Matsuda, Mitsuhiro;
    • Kanamaru, Akihisa
    Publication type:
    Article
    29
    30
    31
    32

    Blockade of glucagon increases muscle mass and alters fiber type composition in mice deficient in proglucagon‐derived peptides.

    Published in:
    Journal of Diabetes Investigation, 2023, v. 14, n. 9, p. 1045, doi. 10.1111/jdi.14032
    By:
    • Ueno, Shinji;
    • Seino, Yusuke;
    • Hidaka, Shihomi;
    • Nakatani, Masashi;
    • Hitachi, Keisuke;
    • Murao, Naoya;
    • Maeda, Yasuhiro;
    • Fujisawa, Haruki;
    • Shibata, Megumi;
    • Takayanagi, Takeshi;
    • Iizuka, Katsumi;
    • Yabe, Daisuke;
    • Sugimura, Yoshihisa;
    • Tsuchida, Kunihiro;
    • Hayashi, Yoshitaka;
    • Suzuki, Atsushi
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39

    Autoimmune autonomic ganglionopathy: an update on diagnosis and treatment.

    Published in:
    Expert Review of Neurotherapeutics, 2018, v. 18, n. 12, p. 953, doi. 10.1080/14737175.2018.1540304
    By:
    • Nakane, Shunya;
    • Mukaino, Akihiro;
    • Higuchi, Osamu;
    • Watari, Mari;
    • Maeda, Yasuhiro;
    • Yamakawa, Makoto;
    • Nakahara, Keiichi;
    • Takamatsu, Koutaro;
    • Matsuo, Hidenori;
    • Ando, Yukio
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46

    Association between neurosarcoidosis with autonomic dysfunction and anti-ganglionic acetylcholine receptor antibodies.

    Published in:
    Journal of Neurology, 2021, v. 268, n. 11, p. 4265, doi. 10.1007/s00415-021-10551-4
    By:
    • Oishi, Makoto;
    • Mukaino, Akihiro;
    • Kunii, Misako;
    • Saito, Asami;
    • Arita, Yukimasa;
    • Koike, Haruki;
    • Higuchi, Osamu;
    • Maeda, Yasuhiro;
    • Abiru, Norio;
    • Yamaguchi, Naohiro;
    • Kawano, Hiroaki;
    • Tsuiki, Eiko;
    • Tanaka, Tomonori;
    • Matsuo, Hidenori;
    • Katsuno, Masahisa;
    • Tanaka, Fumiaki;
    • Tsujino, Akira;
    • Nakane, Shunya
    Publication type:
    Article
    47

    Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial).

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 4, p. 445, doi. 10.1007/s10147-018-1368-2
    By:
    • Fujisawa, Shin;
    • Ueda, Yasunori;
    • Usuki, Kensuke;
    • Kobayashi, Hajime;
    • Kondo, Eisei;
    • Doki, Noriko;
    • Nakao, Takafumi;
    • Kanda, Yoshinobu;
    • Kosugi, Nobuharu;
    • Kosugi, Hiroshi;
    • Kumagai, Takashi;
    • Harada, Hiroshi;
    • Shikami, Masato;
    • Maeda, Yasuhiro;
    • Sakura, Toru;
    • Inokuchi, Koiti;
    • Saito, Akio;
    • Nawa, Yuichiro;
    • Ogasawara, Masahiro;
    • Nishida, Junji
    Publication type:
    Article
    48
    49
    50